Skip Navigation

Strategies for an HIV Cure 2018 (Day 2)

Loading video...

975 Views

Air date: Thursday, October 11, 2018, 8:30:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 975 (508 Live, 467 On-demand)
Category: Conferences
Runtime: 06:13:45
Description: The Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is sponsoring a program-driven meeting focused on the development of innovative strategies to cure HIV infection. The meeting will cover a comprehensive range of topics spanning basic and translational research, drug discovery and development, and clinical research. The purpose of this meeting is to bring together researchers studying HIV persistence and cure strategies, including the NIH-funded Martin Delaney Collaboratories, investigators in complementary disciplines, and community members, to share scientific results and engage in active discussion about the merits of various approaches under investigation. These discussions are intended to stimulate new collaborations and ideas for future research.

For more information go to http://www.cvent.com/events/strategies-for-an-hiv-cure-2018/event-summary-67d64ae8621247079e009b4757f45c9e.aspx
NLM Title: Strategies for an HIV Cure 2018 / NIAID, NIH.
Author: Salzwedel, Karl.
Strategies for an HIV Cure (Meeting)
National Institutes of Health (U.S.),
National Institute of Allergy and Infectious Diseases (U.S.). Division of AIDS,
Publisher:
Abstract: (CIT): The Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is sponsoring a program-driven meeting focused on the development of innovative strategies to cure HIV infection. The meeting will cover a comprehensive range of topics spanning basic and translational research, drug discovery and development, and clinical research. The purpose of this meeting is to bring together researchers studying HIV persistence and cure strategies, including the NIH-funded Martin Delaney Collaboratories, investigators in complementary disciplines, and community members, to share scientific results and engage in active discussion about the merits of various approaches under investigation. These discussions are intended to stimulate new collaborations and ideas for future research.
Subjects: Anti-HIV Agents--therapeutic use
HIV Infections--drug therapy
HIV Infections--virology
Publication Types: Congress
Webcast
 
NLM Classification: WC 503.2
NLM ID: 101736994
CIT Live ID: 28492
Permanent link: https://videocast.nih.gov/watch=28492

The server returned an invalid or unrecognized response